Boyapati A, et al. High Baseline Serum IL-6 Identifies a Subgroup of Rheumatoid Arthritis Patients with Rapid Joint Damage and Clinical Progression and Predicts Increased Sarilumab Treatment Response. ACR 2018, abstract L08.
Iets betere kwaliteit van leven met gecementeerde hemi-artroplastiek na heupfractuur
feb 2022 | Orthopedie